Cargando…
MicroRNA dysregulation as a prognostic biomarker in colorectal cancer
Colorectal cancer (CRC) is one of the most potentially curable cancers, yet it remains the fourth most common overall cause of cancer death worldwide. The identification of robust molecular prognostic biomarkers can refine the conventional tumor–node–metastasis staging system, avoid understaging of...
Autores principales: | Dong, Yujuan, Yu, Jun, Ng, Simon SM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206254/ https://www.ncbi.nlm.nih.gov/pubmed/25342918 http://dx.doi.org/10.2147/CMAR.S35164 |
Ejemplares similares
-
MicroRNA dysregulation in colorectal cancer: a clinical perspective
por: Dong, Y, et al.
Publicado: (2011) -
microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer
por: Yau, Tung On, et al.
Publicado: (2015) -
Expression analysis of microRNA as prognostic biomarkers in colorectal cancer
por: Yang, Jie, et al.
Publicado: (2016) -
microRNA biomarkers in colorectal cancer liver metastasis
por: Huang, Shulin, et al.
Publicado: (2018) -
microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer
por: Zhang, Lijing, et al.
Publicado: (2014)